Elif Tugce Aydin Goker
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Elif Tugce Aydin Goker has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
Diclehan Orhan
Department of Pediatric and Perinatal Pathology Research, Hacettepe University Faculty of Medicine, Ankara, Turkey
2 shared publications- Ozlem Teksam
Division of Pediatric Emergency, Department of Pediatrics, Faculty of Medicine, Hacettepe University, Ankara, Turkey
2 shared publications - Tezer Kutluk
Department of Pediatric Oncology, Hacettepe University Medical School and Cancer Institute, Ankara, Turkey
2 shared publications Ali Varan
Department of Pediatric Oncology, Hacettepe University Faculty of Medicine, Ankara, Turkey
1 shared publicationAlpaslan Alp
Hacettepe University, Faculty of Medicine
1 shared publication- Alpaslan Alp
Department of Medical Microbiology, Hacettepe University Faculty of Medicine, Ankara, Turkiye
1 shared publication
Latest Publications
- 31 December 2024
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 169 (2) , 720-727
Heavy menstrual bleeding in adolescents: Evaluation of diagnostic indicators and treatment preferences
Objective: Heavy menstrual bleeding (HMB) is a significant health concern that may lead to critical medical care and impaired quality of life. The aim of the present study was to identify the clinical indicators of common causes of HMB in adolescents and evaluate the factors influencing the treatment preferences of clinicians.Methods: Between 2010 and 2022, the electronic medical records of adolescents between the ages of 10–18 with HMB were reviewed, and a final of 205 adolescents was included. Clinical, laboratory, and treatment data were retrospectively analyzed.Results: Hypothalamic–pituitary‐ovarian (HPO) axis immaturity was diagnosed in 63.9%, bleeding disorders (BD) in 13.7%, and polycystic ovary syndrome (PCOS) in 12.2% of the patients. The presence of “heavy bleeding” and the bleeding length at presentation were not different between the groups. Patients with a BD presented with lower hemoglobin (Hb) levels (P = 0.019), and more frequently required inpatient admissions (P = 0.005). Of all patients, 34.6% were given only iron, 44.9% were given a low dose, and 15.6% were given a high‐dose hormone treatment. Factors influencing high‐dose hormone regimens were lower Hb levels (P < 0.001), the place of visit (ER rather than the clinic) (P < 0.001), and the presence of multiple ER visits (P < 0.001).Conclusion: Physicians base their decisions to start high‐dose hormonal therapy on objective parameters such as Hb levels and the need for hospitalization, while more precise guidelines are deemed necessary for initiating low‐dose hormonal therapy. Standardized protocols and their practical implementation at the clinical level are needed for the management of HMB in adolescence.
- 31 December 2024
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 169 (2) , 720-727
Heavy menstrual bleeding in adolescents: Evaluation of diagnostic indicators and treatment preferences
Objective: Heavy menstrual bleeding (HMB) is a significant health concern that may lead to critical medical care and impaired quality of life. The aim of the present study was to identify the clinical indicators of common causes of HMB in adolescents and evaluate the factors influencing the treatment preferences of clinicians.Methods: Between 2010 and 2022, the electronic medical records of adolescents between the ages of 10–18 with HMB were reviewed, and a final of 205 adolescents was included. Clinical, laboratory, and treatment data were retrospectively analyzed.Results: Hypothalamic–pituitary‐ovarian (HPO) axis immaturity was diagnosed in 63.9%, bleeding disorders (BD) in 13.7%, and polycystic ovary syndrome (PCOS) in 12.2% of the patients. The presence of “heavy bleeding” and the bleeding length at presentation were not different between the groups. Patients with a BD presented with lower hemoglobin (Hb) levels (P = 0.019), and more frequently required inpatient admissions (P = 0.005). Of all patients, 34.6% were given only iron, 44.9% were given a low dose, and 15.6% were given a high‐dose hormone treatment. Factors influencing high‐dose hormone regimens were lower Hb levels (P < 0.001), the place of visit (ER rather than the clinic) (P < 0.001), and the presence of multiple ER visits (P < 0.001).Conclusion: Physicians base their decisions to start high‐dose hormonal therapy on objective parameters such as Hb levels and the need for hospitalization, while more precise guidelines are deemed necessary for initiating low‐dose hormonal therapy. Standardized protocols and their practical implementation at the clinical level are needed for the management of HMB in adolescence.
- 27 September 2023
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 59 (3) , 483-487
Ganglioneuromas in Childhood: Hacettepe Experience With 70 Cases
- 27 September 2023
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 59 (3) , 483-487
Ganglioneuromas in Childhood: Hacettepe Experience With 70 Cases
- 19 September 2022
- Published by Taylor & Francis in Postgraduate Medicine
- Vol. 135 (1) , 31-37
Clinical features and management of animal bites in an emergency department: a single-center experience
This study aimed to evaluate the clinical features, management, and outcomes of patients with animal bites presented to the pediatric emergency department of a tertiary center.Patients with ICD-10 ...
- 19 September 2022
- Published by Taylor & Francis in Postgraduate Medicine
- Vol. 135 (1) , 31-37
Clinical features and management of animal bites in an emergency department: a single-center experience
This study aimed to evaluate the clinical features, management, and outcomes of patients with animal bites presented to the pediatric emergency department of a tertiary center.Patients with ICD-10 ...
- Open Access
- 18 November 2021
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 33 (1) , e13666
Multicentric Castleman disease in a DOCK8‐deficient patient with Orf virus infection
- 18 November 2021
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 33 (1) , e13666
Open AccessMulticentric Castleman disease in a DOCK8‐deficient patient with Orf virus infection
- Open Access
- 21 June 2021
- Published by Wiley
Multicentric Castleman Disease in a DOCK8 Deficient Patient with Orf Virus Infection
Castleman disease is a rare, heterogeneous disorder that driven by proinflammatory responses. Human herpes virus-8 has a major role in pathogenesis of multicentric Castleman disease. There is also a subgroup of cases, human herpes virus-8 negative, idiopathic multicentric Castleman disease. The role of primary immunodeficiencies in idiopathic Castleman disease are poorly described. DOCK8 deficiency is a combined primary immunodeficiency. It has a broad clinic spectrum including atopy, autoimmunity and cancer. We present a 10-year-old, DOCK8 deficient patient. He had giant lobular capillary hemangiomas on his neck, iliac and gluteal regions and multiple lymphadenopathies. Abdominal lymph node pathology revealed hyaline vascular type Castleman disease and human herpes virus-8 staining was negative. His lesions were shown to be infected with orf virus. Our case is the first case to relate idiopathic multicentric Castleman disease and DOCK8 deficiency; also, very unusual presentation of orf virus infection in humans.
- 21 June 2021
- Published by Wiley
Open AccessMulticentric Castleman Disease in a DOCK8 Deficient Patient with Orf Virus Infection
Castleman disease is a rare, heterogeneous disorder that driven by proinflammatory responses. Human herpes virus-8 has a major role in pathogenesis of multicentric Castleman disease. There is also a subgroup of cases, human herpes virus-8 negative, idiopathic multicentric Castleman disease. The role of primary immunodeficiencies in idiopathic Castleman disease are poorly described. DOCK8 deficiency is a combined primary immunodeficiency. It has a broad clinic spectrum including atopy, autoimmunity and cancer. We present a 10-year-old, DOCK8 deficient patient. He had giant lobular capillary hemangiomas on his neck, iliac and gluteal regions and multiple lymphadenopathies. Abdominal lymph node pathology revealed hyaline vascular type Castleman disease and human herpes virus-8 staining was negative. His lesions were shown to be infected with orf virus. Our case is the first case to relate idiopathic multicentric Castleman disease and DOCK8 deficiency; also, very unusual presentation of orf virus infection in humans.